Surbhi Sidana, MD, is an Assistant Professor at Stanford University, Stanford, CA, and is currently a member of ASH, BMT CTN and ASTCT.
Dr Sidana obtained her medical degree from Maulana Azad Medical College, New Delhi, India, followed by a residency in internal medicine at Cleveland Clinic, Cleveland, OH, in 2015. After this, Dr Sidana completed a fellowship in hematology and oncology in 2018 and a fellowship in plasma cell disorders in 2019, both at the Mayo Clinic, Rochester, MN.
Dr Sidana has received many awards, including the Outstanding Research Fellow award from the Mayo Clinic and the Young Investigator Award from the 10th International Workshop on Waldenström’s macroglobulinemia.
Speaking on novel therapies for plasma cell disorders
Dr Sidana’s main research focus is on the treatment of plasma cell disorders, including multiple myeloma, amyloidosis and other related disorders. In particular, she specializes in the development of novel therapies, biomarkers and the management of treatment-related toxicities. Dr Sidana’s expertise includes blood and marrow transplantation and chimeric antigen receptor (CAR) T-cell therapy.